Posted on 19 January 2013.
Will Forest Labs Earn or Burn Tomorrow?
The big problem for Forest is the fact that it lost patent protection on its blockbuster anti-depressant Lexapro last March. Over the past several quarters, Forest has seen revenue plunge due to the loss, as generic competition from Teva Pharmaceutical …
Full News here – Read more on Motley Fool